EFS
Essex Financial Services’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $342K | Buy |
4,129
+1,563
| +61% | +$130K | 0.02% | 512 |
|
|
2025
Q1 | $208K | Buy |
+2,566
| New | +$208K | 0.02% | 600 |
|
|
2024
Q4 | – | Sell |
-5,115
| Closed | -$502K | – | 662 |
|
|
2024
Q3 | $502K | Buy |
5,115
+2,568
| +101% | +$252K | 0.04% | 379 |
|
|
2024
Q2 | $242K | Buy |
2,547
+285
| +13% | +$27.1K | 0.02% | 534 |
|
|
2024
Q1 | $215K | Sell |
2,262
-2
| -0.1% | -$190 | 0.02% | 496 |
|
|
2023
Q4 | $202K | Buy |
+2,264
| New | +$202K | 0.02% | 483 |
|
|
2023
Q1 | – | Sell |
-2,689
| Closed | -$223K | – | 509 |
|
|
2022
Q4 | $223K | Sell |
2,689
-1,521
| -36% | -$126K | 0.02% | 436 |
|
|
2022
Q3 | $334K | Sell |
4,210
-228
| -5% | -$18.1K | 0.04% | 321 |
|
|
2022
Q2 | $330K | Sell |
4,438
-2,840
| -39% | -$211K | 0.04% | 337 |
|
|
2022
Q1 | $654K | Sell |
7,278
-660
| -8% | -$59.3K | 0.06% | 247 |
|
|
2021
Q4 | $889K | Buy |
7,938
+344
| +5% | +$38.5K | 0.09% | 214 |
|
|
2021
Q3 | $955K | Buy |
7,594
+432
| +6% | +$54.3K | 0.11% | 188 |
|
|
2021
Q2 | $972K | Hold |
7,162
| – | – | 0.14% | 155 |
|
|
2021
Q1 | $972K | Buy |
7,162
+605
| +9% | +$82.1K | 0.17% | 132 |
|
|
2020
Q4 | $923K | Buy |
6,557
+2,635
| +67% | +$371K | 0.18% | 124 |
|
|
2020
Q3 | $437K | Hold |
3,922
| – | – | 0.11% | 175 |
|
|
2020
Q2 | $439K | Buy |
3,922
+27
| +0.7% | +$3.02K | 0.14% | 144 |
|
|
2020
Q1 | $302K | Buy |
+3,895
| New | +$302K | 0.11% | 180 |
|
|
2018
Q2 | – | Sell |
-16,689
| Closed | -$1.46M | – | 355 |
|
|
2018
Q1 | $1.46M | Buy |
+16,689
| New | +$1.46M | 0.29% | 99 |
|
|
2017
Q3 | – | Sell |
-13,983
| Closed | -$1.08M | – | 357 |
|
|
2017
Q2 | $1.08M | Buy |
13,983
+2,708
| +24% | +$209K | 0.23% | 109 |
|
|
2017
Q1 | $782K | Hold |
11,275
| – | – | 0.18% | 126 |
|
|
2016
Q4 | $667K | Sell |
11,275
-2,874
| -20% | -$170K | 0.14% | 147 |
|
|
2016
Q3 | $938K | Sell |
14,149
-450
| -3% | -$29.8K | 0.22% | 110 |
|
|
2016
Q2 | $790K | Sell |
14,599
-6,350
| -30% | -$344K | 0.19% | 123 |
|
|
2016
Q1 | $1.08M | Sell |
20,949
-860
| -4% | -$44.4K | 0.27% | 90 |
|
|
2015
Q4 | $1.53M | Sell |
21,809
-59
| -0.3% | -$4.14K | 0.37% | 71 |
|
|
2015
Q3 | $1.36M | Buy |
21,868
+15,208
| +228% | +$947K | 0.35% | 72 |
|
|
2015
Q2 | $1.68M | Buy |
6,660
+555
| +9% | +$140K | 0.43% | 61 |
|
|
2015
Q1 | $1.38M | Buy |
6,105
+1,290
| +27% | +$291K | 0.35% | 70 |
|
|
2014
Q4 | $898K | Buy |
4,815
+426
| +10% | +$79.4K | 0.23% | 108 |
|
|
2014
Q3 | $685K | Buy |
4,389
+440
| +11% | +$68.7K | 0.2% | 124 |
|
|
2014
Q2 | $608K | Buy |
3,949
+199
| +5% | +$30.6K | 0.18% | 134 |
|
|
2014
Q1 | $534K | Buy |
3,750
+2,000
| +114% | +$285K | 0.17% | 132 |
|
|
2013
Q4 | $228K | Buy |
1,750
+75
| +4% | +$9.77K | 0.08% | 244 |
|
|
2013
Q3 | $216 | Buy |
+1,675
| New | +$216 | 0.07% | 237 |
|